Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Molecular Pharmacology|July 20, 2002
Molecular requisites for drug binding to muscle CLC-1 and renal CLC-K channel revealed by the use of phenoxy-alkyl derivatives of 2-(p-chlorophenoxy)propionic acidAntonella Liantonio, Alessio Accardi, Giuseppe Carbonara, et al.
European Journal of Medicinal Chemistry|March 19, 2013
Molecular determinants for nuclear receptors selectivity: chemometric analysis, dockings and site-directed mutagenesis of dual peroxisome proliferator-activated receptors α/γ agonistsAntonio Carrieri, Marco Giudici, Mariagiovanna Parente, et al.
Bioorganic & Medicinal Chemistry Letters|July 6, 2019
Synthesis of novel benzothiazole amides: Evaluation of PPAR activity and anti-proliferative effects in paraganglioma, pancreatic and colorectal cancer cell linesAlessandra Ammazzalorso, Laura De Lellis, Rosalba Florio, et al.
Journal of Medicinal Chemistry|May 19, 2021
Thiazolidinedione "Magic Bullets" Simultaneously Targeting PPARγ and HDACs: Design, Synthesis, and Investigations of their In Vitro and In Vivo Antitumor EffectsKalpana Tilekar, Jessica D Hess, Neha Upadhyay, et al.
European Journal of Medicinal Chemistry|January 12, 2017
New diphenylmethane derivatives as peroxisome proliferator-activated receptor alpha/gamma dual agonists endowed with anti-proliferative effects and mitochondrial activityLuca Piemontese, Carmen Cerchia, Antonio Laghezza, et al.
European Journal of Medicinal Chemistry|March 24, 2022
A chemoinformatics search for peroxisome proliferator-activated receptors ligands revealed a new pan-agonist able to reduce lipid accumulation and improve insulin sensitivitySabina Sblano, Carmen Cerchia, Antonio Laghezza, et al.
European Journal of Medicinal Chemistry|December 16, 2014
Design, synthesis and biological evaluation of a class of bioisosteric oximes of the novel dual peroxisome proliferator-activated receptor α/γ ligand LT175Luca Piemontese, Giuseppe Fracchiolla, Antonio Carrieri, et al.
The Journal of Biological Chemistry|April 4, 2007
Insights into the mechanism of partial agonism: crystal structures of the peroxisome proliferator-activated receptor gamma ligand-binding domain in the complex with two enantiomeric ligandsGiorgio Pochetti, Cristina Godio, Nico Mitro, et al.
Scientific Reports|November 2, 2017
Novel Benzylidene Thiazolidinedione Derivatives as Partial PPARγ Agonists and their Antidiabetic Effects on Type 2 DiabetesSabina Yasmin, Fabio Capone, Antonio Laghezza, et al.
Antioxidants (Basel, Switzerland)|September 23, 2022
Novel Phenothiazine/Donepezil-like Hybrids Endowed with Antioxidant Activity for a Multi-Target Approach to the Therapy of Alzheimer's DiseaseAlessia Carocci, Alexia Barbarossa, Rosalba Leuci, et al.
Pageof 9